(Q43825896)

27 November 2017

title

RSR13, a potential athletic performance enhancement agent: detection in urine by gas chromatography/mass spectrometry (English)

1 reference

27 November 2017

Breidbach A

1

1 reference

27 November 2017

Catlin DH

series ordinal

2

1 reference

27 November 2017

publication date

1 January 2001

1 reference

Rapid Communications in Mass Spectrometry

27 November 2017

published in

1 reference

27 November 2017

volume

15

1 reference

27 November 2017

issue

24

1 reference

27 November 2017

page(s)

2379-2382

1 reference

describes a project that uses

27 November 2017

gas chromatography-mass spectrometry

1 reference

based on heuristic

inferred from title

cites work

Allosteric modifiers of hemoglobin: 2-[4-[[(3,5-disubstituted anilino)carbonyl]methyl]phenoxy]-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats

1 reference

Effects of the allosteric modification of hemoglobin on brain oxygen and infarct size in a feline model of stroke

21 January 2018

1 reference

The rationale for, and effects of oxygen delivery enhancement to ischemic brain in a feline model of human stroke

21 January 2018

1 reference

Phase I trial to determine the safety, pharmacodynamics, and pharmacokinetics of RSR13, a novel radioenhancer, in newly diagnosed glioblastoma multiforme.

21 January 2018

1 reference

A phase I study of RSR13, a radiation-enhancing hemoglobin modifier: tolerance of repeated intravenous doses and correlation of pharmacokinetics with pharmacodynamics

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/RCM.523

1 reference

27 November 2017

1 reference